Insulin aspart
门冬胰岛素
Report date: 2026/03/31 20:00:21
Base Information
Drug NameInsulin aspart
Drug Alias Name +[15]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[14]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1999/09/07
Country/Territory +[36]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A
Develop Information
Active CompaniesNovo Nordisk IncYale UniversityThe University Of Iowa +[4]
Inactive CompaniesWake Forest University Health SciencesMedical University Of GrazAarhus University +[10]
Active Indications +[5]
Inactive Indications +[9]